Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PALBOCICLIB Cause Electrocardiogram qt prolonged? 161 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 161 reports of Electrocardiogram qt prolonged have been filed in association with PALBOCICLIB (Ibrance). This represents 0.2% of all adverse event reports for PALBOCICLIB.

161
Reports of Electrocardiogram qt prolonged with PALBOCICLIB
0.2%
of all PALBOCICLIB reports
7
Deaths
35
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From PALBOCICLIB?

Of the 161 reports, 7 (4.3%) resulted in death, 35 (21.7%) required hospitalization, and 20 (12.4%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 161 reports have been filed with the FAERS database.

What Other Side Effects Does PALBOCICLIB Cause?

Fatigue (15,190) White blood cell count decreased (11,273) Neoplasm progression (10,885) Death (8,410) Nausea (8,189) Neutropenia (6,423) Alopecia (6,201) Diarrhoea (5,635) Asthenia (3,660) Off label use (3,405)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which PALBOCICLIB Alternatives Have Lower Electrocardiogram qt prolonged Risk?

PALBOCICLIB vs PALIPERIDONE PALBOCICLIB vs PALIVIZUMAB PALBOCICLIB vs PALONOSETRON PALBOCICLIB vs PAMIDRONATE PALBOCICLIB vs PAMIDRONIC ACID

Related Pages

PALBOCICLIB Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged PALBOCICLIB Demographics